A detailed history of Rockland Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Rockland Trust CO holds 11,418 shares of LLY stock, worth $8.3 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
11,418
Previous 11,591 1.49%
Holding current value
$8.3 Million
Previous $10.5 Million 3.61%
% of portfolio
0.5%
Previous 0.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$772.14 - $960.02 $133,580 - $166,083
-173 Reduced 1.49%
11,418 $10.1 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $6.53 Million - $8.19 Million
9,011 Added 349.26%
11,591 $10.5 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $200,163 - $267,790
-338 Reduced 11.58%
2,580 $2.01 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $8.52 Million - $10 Million
-16,231 Reduced 84.76%
2,918 $1.7 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $137,799 - $189,978
-317 Reduced 1.63%
19,149 $10.3 Million
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $2.53 Million - $3.38 Million
-7,204 Reduced 27.01%
19,466 $9.13 Million
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $48,147 - $56,547
-155 Reduced 0.58%
26,670 $9.16 Million
Q4 2022

Jan 24, 2023

SELL
$321.55 - $374.67 $559,497 - $651,925
-1,740 Reduced 6.09%
26,825 $9.81 Million
Q3 2022

Oct 19, 2022

SELL
$296.48 - $337.87 $558,271 - $636,209
-1,883 Reduced 6.18%
28,565 $9.24 Million
Q2 2022

Jul 13, 2022

SELL
$278.73 - $327.27 $1.11 Million - $1.3 Million
-3,981 Reduced 11.56%
30,448 $9.87 Million
Q1 2022

Apr 18, 2022

SELL
$234.69 - $291.66 $2.41 Million - $2.99 Million
-10,255 Reduced 22.95%
34,429 $9.86 Million
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $208,435 - $258,670
-927 Reduced 2.03%
44,684 $12.3 Million
Q3 2021

Oct 25, 2021

BUY
$221.6 - $272.71 $318,439 - $391,884
1,437 Added 3.25%
45,611 $10.5 Million
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $34,665 - $44,839
-192 Reduced 0.43%
44,174 $10.1 Million
Q1 2021

Apr 22, 2021

BUY
$164.32 - $212.72 $591,880 - $766,217
3,602 Added 8.84%
44,366 $8.29 Million
Q4 2020

Jan 04, 2021

SELL
$130.46 - $172.63 $9,393 - $12,429
-72 Reduced 0.18%
40,764 $6.88 Million
Q3 2020

Oct 08, 2020

BUY
$146.22 - $169.13 $1,169 - $1,353
8 Added 0.02%
40,836 $6.04 Million
Q2 2020

Jul 09, 2020

SELL
$136.42 - $164.18 $308,718 - $371,539
-2,263 Reduced 5.25%
40,828 $6.7 Million
Q1 2020

Apr 16, 2020

SELL
$119.05 - $147.35 $385,841 - $477,561
-3,241 Reduced 7.0%
43,091 $5.98 Million
Q4 2019

Jan 06, 2020

BUY
$106.92 - $132.43 $119,750 - $148,321
1,120 Added 2.48%
46,332 $6.09 Million
Q3 2019

Oct 11, 2019

BUY
$106.79 - $116.16 $139,574 - $151,821
1,307 Added 2.98%
45,212 $4.85 Million
Q2 2019

Jul 05, 2019

BUY
$110.79 - $129.32 $66,917 - $78,109
604 Added 1.39%
43,905 $4.86 Million
Q1 2019

Apr 08, 2019

BUY
$111.31 - $131.02 $696,689 - $820,054
6,259 Added 16.9%
43,301 $5.62 Million
Q4 2018

Jan 16, 2019

SELL
$105.9 - $118.64 $194,856 - $218,297
-1,840 Reduced 4.73%
37,042 $4.29 Million
Q3 2018

Oct 05, 2018

SELL
$85.86 - $107.31 $403,112 - $503,820
-4,695 Reduced 10.77%
38,882 $4.17 Million
Q2 2018

Jul 06, 2018

SELL
$75.7 - $86.88 $86,827 - $99,651
-1,147 Reduced 2.56%
43,577 $3.72 Million
Q1 2018

Apr 10, 2018

BUY
$74.21 - $87.6 $172,167 - $203,232
2,320 Added 5.47%
44,724 $3.46 Million
Q4 2017

Jan 11, 2018

BUY
$81.94 - $87.89 $54,080 - $58,007
660 Added 1.58%
42,404 $3.58 Million
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $3.22 Million - $3.57 Million
41,744
41,744 $3.57 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rockland Trust CO Portfolio

Follow Rockland Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.